We are live on
!
Find out more
GCM
Geneva Capital Management Portfolio holdings
AUM
$4.36B
1-Year Est. Return
17.81%
This Fund
S&P 500
This Quarter
Est. Return
-0.4%
1 Year Est. Return
+17.81%
3 Year Est. Return
+59.44%
5 Year Est. Return
+75.65%
10 Year Est. Return
–
AUM
$4.33B
AUM Growth
-$15.9M
(-0.37%)
Cap. Flow
+$139M
Cap. Flow
% of AUM
3.22%
Top 10 Holdings %
Top 10 Hldgs %
24.98%
Holding
130
New
2
Increased
58
Reduced
68
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Certara
CERT
|
+$21.6M |
| 2 |
Mesa Laboratories
MLAB
|
+$19.1M |
| 3 |
Omnicell
OMCL
|
+$13.1M |
| 4 |
ePlus
PLUS
|
+$9.74M |
| 5 |
NVEE
NV5 Global
NVEE
|
+$9.45M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LHCG
LHC Group LLC
LHCG
|
+$39.4M |
| 2 |
PETQ
PetIQ, Inc. Class A Common Stock
PETQ
|
+$5.02M |
| 3 |
iShares Russell 2000 Growth ETF
IWO
|
+$3.97M |
| 4 |
Cerence
CRNC
|
+$3.22M |
| 5 |
Generac Holdings
GNRC
|
+$2.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.64% |
| 2 | Industrials | 25.88% |
| 3 | Healthcare | 17.08% |
| 4 | Consumer Discretionary | 8.12% |
| 5 | Financials | 7.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Cognex
CGNX
$11.3B
| $5.88M | 0.14% |
141,906
-10,989
| -7% | -$498K |
|
102
Fortune Brands Innovations
FBIN
$6.06B
| $5.72M | 0.13% |
124,600
-2,625
| -2% | -$143K |
|
103
Paycom
PAYC
$9.69B
| $4.99M | 0.12% |
15,117
+253
| +2% | +$87.1K |
|
104
Danaher
DHR
$144B
| $4.51M | 0.1% |
19,704
-7
| -0% | -$1.71K |
|
105
Costco
COST
$420B
| $4.28M | 0.1% |
9,067
-3
| -0% | -$1.56K |
|
106
Thermo Fisher Scientific
TMO
$220B
| $4.26M | 0.1% |
8,400
-3
| -0% | -$1.68K |
|
107
Lowe's Companies
LOW
$125B
| $3.95M | 0.09% |
21,031
-8
| -0% | -$1.56K |
|
108
Charles River Laboratories
CRL
$12.8B
| $3.93M | 0.09% |
19,987
-2,189
| -10% | -$473K |
|
109
Microsoft
MSFT
$3.71T
| $3.9M | 0.09% |
16,742
-6
| -0% | -$1.58K |
|
110
iShares Russell Mid-Cap Growth ETF
IWP
$20.7B
| $3.8M | 0.09% |
48,471
+44,272
| +1,054% | +$3.81M |
|
111
Freshpet
FRPT
$3.22B
| $3.8M | 0.09% |
75,865
-7,386
| -9% | -$348K |
|
112
Alphabet (Google) Class A
GOOGL
$4.33T
| $3.62M | 0.08% |
37,805
+25
| +0.1% | +$2.77K |
|
113
TJX Companies
TJX
$178B
| $3.13M | 0.07% |
50,459
-14
| -0% | -$879 |
|
|
114
iShares Russell 2000 Growth ETF
IWO
$15B
| $3.12M | 0.07% |
15,099
-17,625
| -54% | -$3.97M |
|
|
115
Cerence
CRNC
$413M
| $3.11M | 0.07% |
197,307
-143,179
| -42% | -$3.22M |
|
116
Edwards Lifesciences
EW
$51.7B
| $3.02M | 0.07% |
36,561
-12
| -0% | -$1.16K |
|
117
Visa
V
$677B
| $2.92M | 0.07% |
16,452
-5
| -0% | -$1.02K |
|
118
Microchip Technology
MCHP
$46B
| $2.83M | 0.07% |
46,363
-141
| -0.3% | -$9.26K |
|
119
Twilio
TWLO
$36.6B
| $2.59M | 0.06% |
37,429
-3,661
| -9% | -$293K |
|
120
Marvell Technology
MRVL
$196B
| $2.4M | 0.06% |
55,897
-18
| -0% | -$891 |
|
121
Adobe
ADBE
$105B
| $2.31M | 0.05% |
8,401
-3
| -0% | -$1.14K |
|
122
Walmart Inc
WMT
$890B
| $2.3M | 0.05% |
53,271
-18
| -0% | -$789 |
|
123
Salesforce
CRM
$158B
| $1.96M | 0.05% |
13,638
-4
| -0% | -$678 |
|
124
Ecolab
ECL
$79.9B
| $1.7M | 0.04% |
11,762
-3
| -0% | -$487 |
|
125
Walt Disney
DIS
$181B
| $1.5M | 0.03% |
15,954
-6
| -0% | -$642 |
|
Similar funds
SFM
EC
EQF
NEI
FIS
CFO
Geneva Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Geneva Capital Management held 130 positions worth $4.33B, down 0.37% from $4.35B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Geneva Capital Management deployed $139M of net new capital in Q3 2022, opening 2 new positions and adding to 58 existing holdings. Its largest new stake was Certara: 1,170,270 shares worth $15.5M.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 34% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was LHC Group LLC, an estimated $39.4M trimmed.
- Geneva Capital Management's largest Q3 2022 buy was Certara: 1,170,270 shares worth $15.5M.
- Geneva Capital Management added most to Omnicell in Q3 2022, an estimated $13.1M increase.
- Geneva Capital Management's biggest Q3 2022 reduction was LHC Group LLC, cutting an estimated $39.4M.
- Geneva Capital Management fully exited VF Corp in Q3 2022, selling an estimated $823K.
- Geneva Capital Management's ten largest holdings make up 25% of its $4.33B portfolio in Q3 2022.
- Geneva Capital Management opened 2 new positions and closed 2 in Q3 2022.
- Geneva Capital Management's portfolio value fell 0.37% quarter-over-quarter to $4.33B.
Based on Geneva Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.